Matches in SemOpenAlex for { <https://semopenalex.org/work/W4251663150> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4251663150 endingPage "2200" @default.
- W4251663150 startingPage "2196" @default.
- W4251663150 abstract "Interleukin-1 receptor antagonist (IL-1ra) is a 22-Kd protein that shares homology with IL-1 beta, binds to the IL-1 receptor, but has no known agonist properties. This inhibitor appears to be the first cytokine whose sole function is to block the actions of another cytokine. Exogenous IL-1ra administration has been shown to reduce mortality in experimental septic shock. We now report that IL-1ra is endogenously produced and circulates in experimental inflammation and in clinical disease. After experimental endotoxemia in human volunteers, IL-1ra concentrations increase from a baseline concentration of 460 +/- 200 pg mL-1 to 14,870 +/- 290 pg mL-1 at 3 hours (P less than .05). IL-1ra is also detectable in all plasma samples from critically ill patients with a mean concentration of 8,680 +/- 2,060 pg mL-1 (range 320 to 55,370 pgs mL-1). In nonhuman primates, Escherichia coli septic shock induces elevated plasma levels of IL-4ra (P less than .05). However, in animals that eventually succumb to septic shock, Il-1ra appears in quantities presumed inadequate to block the pathologic sequelae associated with high IL-1 beta levels. The findings suggest that IL-1ra may play a role in modulating the systemic host responses to a variety of nonlethal disease states by altering the balance between cytokines and their antagonists." @default.
- W4251663150 created "2022-05-12" @default.
- W4251663150 creator A5005742957 @default.
- W4251663150 creator A5010647188 @default.
- W4251663150 creator A5022445571 @default.
- W4251663150 creator A5033723756 @default.
- W4251663150 creator A5033959334 @default.
- W4251663150 creator A5038744233 @default.
- W4251663150 creator A5052314658 @default.
- W4251663150 creator A5081164839 @default.
- W4251663150 creator A5081662602 @default.
- W4251663150 date "1992-05-01" @default.
- W4251663150 modified "2023-09-27" @default.
- W4251663150 title "Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease" @default.
- W4251663150 doi "https://doi.org/10.1182/blood.v79.9.2196.bloodjournal7992196" @default.
- W4251663150 hasPublicationYear "1992" @default.
- W4251663150 type Work @default.
- W4251663150 citedByCount "7" @default.
- W4251663150 countsByYear W42516631502021 @default.
- W4251663150 countsByYear W42516631502023 @default.
- W4251663150 crossrefType "journal-article" @default.
- W4251663150 hasAuthorship W4251663150A5005742957 @default.
- W4251663150 hasAuthorship W4251663150A5010647188 @default.
- W4251663150 hasAuthorship W4251663150A5022445571 @default.
- W4251663150 hasAuthorship W4251663150A5033723756 @default.
- W4251663150 hasAuthorship W4251663150A5033959334 @default.
- W4251663150 hasAuthorship W4251663150A5038744233 @default.
- W4251663150 hasAuthorship W4251663150A5052314658 @default.
- W4251663150 hasAuthorship W4251663150A5081164839 @default.
- W4251663150 hasAuthorship W4251663150A5081662602 @default.
- W4251663150 hasBestOaLocation W42516631501 @default.
- W4251663150 hasConcept C126322002 @default.
- W4251663150 hasConcept C134018914 @default.
- W4251663150 hasConcept C149892131 @default.
- W4251663150 hasConcept C170493617 @default.
- W4251663150 hasConcept C203014093 @default.
- W4251663150 hasConcept C2776252253 @default.
- W4251663150 hasConcept C2776885963 @default.
- W4251663150 hasConcept C2776914184 @default.
- W4251663150 hasConcept C2777628635 @default.
- W4251663150 hasConcept C2778122271 @default.
- W4251663150 hasConcept C2778384902 @default.
- W4251663150 hasConcept C2778690821 @default.
- W4251663150 hasConcept C2778938600 @default.
- W4251663150 hasConcept C2781300812 @default.
- W4251663150 hasConcept C71924100 @default.
- W4251663150 hasConcept C74172505 @default.
- W4251663150 hasConcept C86803240 @default.
- W4251663150 hasConceptScore W4251663150C126322002 @default.
- W4251663150 hasConceptScore W4251663150C134018914 @default.
- W4251663150 hasConceptScore W4251663150C149892131 @default.
- W4251663150 hasConceptScore W4251663150C170493617 @default.
- W4251663150 hasConceptScore W4251663150C203014093 @default.
- W4251663150 hasConceptScore W4251663150C2776252253 @default.
- W4251663150 hasConceptScore W4251663150C2776885963 @default.
- W4251663150 hasConceptScore W4251663150C2776914184 @default.
- W4251663150 hasConceptScore W4251663150C2777628635 @default.
- W4251663150 hasConceptScore W4251663150C2778122271 @default.
- W4251663150 hasConceptScore W4251663150C2778384902 @default.
- W4251663150 hasConceptScore W4251663150C2778690821 @default.
- W4251663150 hasConceptScore W4251663150C2778938600 @default.
- W4251663150 hasConceptScore W4251663150C2781300812 @default.
- W4251663150 hasConceptScore W4251663150C71924100 @default.
- W4251663150 hasConceptScore W4251663150C74172505 @default.
- W4251663150 hasConceptScore W4251663150C86803240 @default.
- W4251663150 hasIssue "9" @default.
- W4251663150 hasLocation W42516631501 @default.
- W4251663150 hasOpenAccess W4251663150 @default.
- W4251663150 hasPrimaryLocation W42516631501 @default.
- W4251663150 hasRelatedWork W132959013 @default.
- W4251663150 hasRelatedWork W1427355319 @default.
- W4251663150 hasRelatedWork W1969531010 @default.
- W4251663150 hasRelatedWork W2006549602 @default.
- W4251663150 hasRelatedWork W2031364456 @default.
- W4251663150 hasRelatedWork W2036332752 @default.
- W4251663150 hasRelatedWork W2242850553 @default.
- W4251663150 hasRelatedWork W2463864198 @default.
- W4251663150 hasRelatedWork W4251663150 @default.
- W4251663150 hasRelatedWork W17630582 @default.
- W4251663150 hasVolume "79" @default.
- W4251663150 isParatext "false" @default.
- W4251663150 isRetracted "false" @default.
- W4251663150 workType "article" @default.